We invite you to explore the data, by clicking on each nation outlined in bold. You will then see companies headquartered in the country displayed on a graph showing the gains in their market capitalisation since the pandemic.
In her first piece for the ERC, Jacque Mallender has co-authored this blog with health economists Trishal Boodhna and Calum Jones, consulting at McCann Health. It discusses how crises throughout history can offer governments, and other actors, the impetus for innovation and the adoption of new healthcare technologies with pace.
Spending on research and development has been comparatively low in the UK for some time, but it has decreased since the financial crisis.